Erbitux Trials Disappoint

Erbitux Trials Disappoint

Red Herring - Late-phase clinical trial fails to increase overall survival rate for colorectal cancer. November 7, 2006 ImClone and Bristol She points out that patients in the control group of the Canadian study were allowed to cross over to the treatment arm and

BioCurex Discusses PSA Article from the Journal of the National Cancer
PrimeZone - Thirdly, we cannot be certain that if a life-threatening prostate cancer had been identified by PSA velocity earlier in the natural history of the disease, treatment at that point in time would have changed the outcome. Rather, PSA velocity might

SkinMedica and Galderma to Co-Promote Desonate(TM)
PR Newswire - an agreement with Galderma Laboratories, L.P. for the co-promotion of Desonate(TM) (desonide) Gel 0.05% for treatment of mild rosacea, fungal nail infections, psoriasis, seborrheic dermatitis, hyper-pigmentation disorders, non-melanoma skin cancer

Bioniche Plans to Liquidate Two Remaining Assets Associated With Irish
Phramalive.com - Resources must remain focused on two priorities: our proprietary cancer treatment that is entering Phase III trials and our E. coli O157:H7 cattle vaccine that is seeking marketing registrations." In human cancer, Mycobacterial Cell Wall-DNA Complex

Oxford BioMedica Commences Phase III trial oF TroVax in Renal Cancer
Phramalive.com - The Phase III TRIST study is designed to demonstrate definitively that TroVax is effective as a treatment for this aggressive form of kidney cancer. The clinical experience with TroVax in over 150 patients has shown indications of its therapeutic

Cancer Center's work appreciated
News-Review - How thankful I was when my last treatment occurred the day before Thanksgiving in 2005. I am one of the 55 women in Roseburg who were diagnosed with breast cancer last year. This is truly a life-changing experience, but fortunately, it was caught

Explore A Deadly, Hard-To-Detect Form Of Cancer
KPHO - IBC is rare, accounting for only 5 percent of breast cancer cases, but because of the symptoms, it's often overlooked. With aggressive and prompt treatment, 80 percent of IBC patients survive for up to 10 years. IBC can begin to develop in very young

New Radiation Technique for Breast Cancer
SAWF News Connect - Women with breast cancer who undergo a new radiation technique called intensity modulated radiation therapy (IMRT) after surgery are three times less likely to have severe skin burn from the treatment compared to standard radiation therapy Breast

Coach’s attitude on life inspires players
Altoona Mirror - This past June, Zauzig — under the care of the cancer treatment staff at the Altoona Regional Health System, Altoona Hospital Campus — was getting his intravenous medical care daily there for four straight weeks, but despite the associated nausea

Study finds holographic imaging system promising for cancer treatment
PhysOrg - James Chu, PhD, professor and director of medical physics for the department of radiation oncology at Rush University Medical Center, is studying the potential of the "PerspectaRAD" Spatial 3D system for radiation treatment planning. Credit: Rush